Metagenomi, Inc. Common Stock
NASDAQ Global SelectTotal Valuation
Metagenomi, Inc. Common Stock carries a market capitalization of 30.38M, placing it among publicly traded companies globally. Its enterprise value stands at -37.99M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 30.38M |
| Enterprise Value | -37.99M |
Share Statistics
Metagenomi, Inc. Common Stock currently has 37.78M shares outstanding.
| Shares Outstanding | 37.78M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 3.29, and the price-to-book ratio stands at 0.40.
| PE Ratio | N/A |
| PS Ratio | 3.29 |
| PB Ratio | 0.40 |
| P/TBV Ratio | 0.40 |
| P/FCF Ratio | -0.52 |
| P/OCF Ratio | -0.52 |
Financial Position
Metagenomi, Inc. Common Stock maintains a current ratio of 4.50, meaning it holds 4.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.50 |
| Quick Ratio | 4.37 |
| Debt / Equity | 33.51 |
| Debt / EBITDA | -0.40 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | -60.61 |
| Return on Assets (ROA) | -41.91 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
| Income Tax | -190,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
Metagenomi, Inc. Common Stock's stock has declined approximately -75.99104% over the past 52 weeks. The 50-day moving average sits at 1.12, while the 200-day moving average is 1.34.
| Beta (5Y) | N/A |
| 52-Week Price Change | -75.99104% |
| 50-Day Moving Average | 1.12 |
| 200-Day Moving Average | 1.34 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Metagenomi, Inc. Common Stock generated 13.56M in revenue and converted that into -93.46M in net income, yielding earnings per share of -2.49. EBITDA reached -95.40M, while operating income came in at -100.57M.
| Revenue | 13.56M |
| Gross Profit | N/A |
| Operating Income | -100.57M |
| Pretax Income | -93.65M |
| Net Income | -93.46M |
| EBITDA | -95.40M |
| EBIT | -100.57M |
| Earnings Per Share (EPS) | -2.49 |
Balance Sheet
Metagenomi, Inc. Common Stock holds 120.66M in cash and equivalents against 37.72M in total debt, resulting in a net debt position of -39.03M. Total book value stands at 112.57M, with working capital of 96.84M providing operational flexibility.
| Cash & Cash Equivalents | 120.66M |
| Total Debt | 37.72M |
| Net Debt | -39.03M |
| Equity (Book Value) | 112.57M |
| Book Value Per Share | 2.98 |
| Working Capital | 96.84M |
Cash Flow
Metagenomi, Inc. Common Stock produced -85.49M in operating cash flow over the past twelve months. After subtracting -309,000.00 in capital expenditures, free cash flow totaled -85.80M - equivalent to -2.29 per share.
| Operating Cash Flow | -85.49M |
| Capital Expenditures | -309,000.00 |
| Free Cash Flow | -85.80M |
| FCF Per Share | -2.29 |
Margins
Metagenomi, Inc. Common Stock operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -741.58 and net profit margin of -689.20 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | -741.58 |
| Pretax Margin | -690.60 |
| Profit Margin | -689.20 |
| EBITDA Margin | -703.50 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.16 |
| FCF Yield | -190.72 |
Scores
Metagenomi, Inc. Common Stock posts an Altman Z-Score of -3.64, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -3.64 |